dihexa nephrotoxicity kidney VUCA Nephrotoxicity of recent anti-cancer agents

In 65.1% of the samples, the declared active pharmaceutical ingredients (APIs) were present, whereas in 34.9%, they were not

It inhibits the release of pro-inflammatory factors in response to TLR4 stimulation and induces immune tolerance, a non-butyrate-dependent effect (99)

As per the latest diagnostic criteria, MetS necessitates the presence of any three out of the following five conditions: elevated fasting glucose or type 2 diabetes (T2D), hypertriglyceridemia, lowered high-density lipoprotein (HDL) cholesterol levels, central obesity, or hypertension (Tilg et al., 2020)

Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial

M.MuellerM